検索結果一覧

一般口演 / Oral Session

【E】一般口演 16 (Oral Session 16) :MDS:Clinical Research 3
 
日程
2013年10月11日(金)
時間
10:00 - 11:30
会場
第14会場 / Room No.14 (札幌市教育文化会館 3F 研修室305)
座長・司会
石川 隆之 (Takayuki Ishikawa):1
1:Department of Hematology, Kobe City Medical Center General Hospital, Japan

前へ戻る


WT-1 expression level in BM is the great prognostic marker with Revised IPSS

演題番号 : OS-1-78

小林 寿美子 (Sumiko Kobayashi):1,2、上田 恭典 (Yasunori Ueda):2、黒川 峰夫 (Mineo Kurokawa):2、田村 秀人 (Hideto Tamura):2、緒方 清行 (Kiyoyuki Ogata):2、檀 和夫 (Kazuo Dan):2、柴山 浩彦 (Hirohiko Shibayama):2、木原 里香 (Rika Kihara):2、恵美 宣彦 (Nobuhiko Emi):2、泉二 登志子 (Toshiko Motoji):2、佐々木 光 (Ko Sasaki):2、臼杵 憲祐 (Kensuke Usuki):2、小川 啓恭 (Hiroyasu Ogawa):2、佐倉 徹 (Toru Sakura):2、大屋敷 一馬 (Kazuma Ohyashiki):2、小澤 敬也 (Keiya Ozawa):2、今井 陽俊 (Kiyotoshi Imai):2、宮崎 泰司 (Yasushi Miyazaki):2、森田 泰慶 (Yasuyoshi Morita):2、松田 晃 (Akira Matsuda):2、通山 薫 (Kaoru Tohyama):2、角元 慶二 (Keiji Kakumoto):2、古賀 大輔 (Daisuke Koga):2、玉置 広哉 (Hiroya Tamaki):2、三谷 絹子 (Kinuko Mitani):2、直江 知樹 (Tomoki Naoe):2、杉山 治夫 (Haruo Sugiyama):2

1:Dept of Hematology and Rheumatology, Nihon University、2:WT1 mRNA Assay Kit MDS Research Group

WT-1 expression level in BM is the great prognostic marker with Revised IPSS

Serum microRNA-21 as a potent biomarker for response to hypomethylating agents in myelodysplastic syndromes

演題番号 : OS-1-79

June-Won Cheong (丁 晙元):1、Yundeok Kim:1、Yeo-Kyeoung Kim:2、Ju-In Eom:3、Hoi-Kyung Jeung:1、Soo Jeong Kim:1、Dohyu Hwang:1、Jin Seok Kim:1、Hyeuong Joon Kim:2、Yoo Hong Min:1

1:Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea、2:Department of Internal Medicine, Chonnam National University Hwasun Hospital, Jeonnam, Korea、3:Medical Research Center, Yonsei University College of Medicine, Seoul, Korea

Serum microRNA-21 as a potent biomarker for response to hypomethylating agents in myelodysplastic syndromes

Bone marrow imaging of humeral and femoral marrow by multi-detector computed tomography in MDS

演題番号 : OS-1-80

鵜飼 知嵩 (Tomotaka Ugai):1、津田 健司 (Kenji Tsuda):2、杉原 裕基 (Hiroki Sugihara):2、西田 有毅 (Yuki Nishida):2、山倉 昌之 (Masayuki Yamakura):2、竹内 正美 (Masami Takeuchi):2、末永 孝生 (Kosei Matsue):2

1:Department of Hematology, Saitama Medical Center, Jichi Medical University、2:Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center

Bone marrow imaging of humeral and femoral marrow by multi-detector computed tomography in MDS

A nationwide survey of hypoplastic myelodysplastic syndrome (A multicenter retrospective study)

演題番号 : OS-1-81

小林 隆 (Takashi Kobayashi):1、南谷 泰仁 (Yasuhito Nannya):1、市川 幹 (Motoshi Ichikawa):1、小原 尚恵 (Takae Kohara):2、小船 雅義 (Masayoshi Kobune):3、原田 浩徳 (Hironori Harada):4、米村 雄士 (Yuji Yonemura):5、松田 晃 (Akira Matsuda):6、川端 浩 (Hiroshi Kawabata):7、通山 薫 (Kaoru Tohyama):8、宮崎 泰司 (Yasushi Miyazaki):9、黒川 峰夫 (Mineo Kurokawa):1

1:Dept. Hematology and Oncology, the University of Tokyo, Tokyo, Japan、2:Department of Hematology and Oncology, Osaka University, Osaka, Japan、3:Dept. Medical Oncology and Hematology, Sapporo Medical University, Sapporo, Japan、4:Res. Inst. Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan、5:Dept. Transfusion Medicine and Cell Therapy, Kumamoto University, Kumamoto, Japan、6:Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan、7:Dept. Hematology and Oncology, Kyoto University, Kyoto, Japan、8:Dept. Laboratory Medicine (Laboratory Hematology), Kawasaki Medical School, Kurashiki, Japan、9:Dept. Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

A nationwide survey of hypoplastic myelodysplastic syndrome (A multicenter retrospective study)

The positive impact of azacitidine on survival of high-risk MDS

演題番号 : OS-1-82

竹田 淳恵 (June Takeda):1、数馬 安浩 (Yasuhiro Kazuma):1、長畑 洋佑 (Yosuke Nagahata):1、船山 由樹 (Yuki Funayama):1、山内 寛彦 (Nobuhiko Yamauchi):1、小野 祐一郎 (Yuichiro Ono):1、田端 淑恵 (Sumie Tabata):1、米谷 昇 (Noboru Yonetani):1、松下 章子 (Akiko Matsushita):1、石川 隆之 (Takayuki Ishikawa):1

1:Dept. of Hematology, Kobe City General Hospital, Japan

The positive impact of azacitidine on survival of high-risk MDS

Clinical and experimental assessment of 5-azacytidine resistance in patients with MDS

演題番号 : OS-1-83

浅野 倫代 (Michiyo Asano):1、今西 哲 (Satoshi Imanishi):2、梅津 知宏 (Tomohiro Umezu):2,3、大屋敷 純子 (Junko Ohyashiki):2、大屋敷 一馬 (Kazuma Ohyashiki):1,3

1:Department of Hematology, Tokyo Medical University、2:Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University、3:Department of Molecular Science, Tokyo Medical University

Clinical and experimental assessment of 5-azacytidine resistance in patients with MDS

Preliminary results of a randomized dose-finding study of darbepoetin alfa in MDS in Japan and Korea

演題番号 : OS-1-84

柴山 浩彦 (Hirohiko Shibayama):1、原田 浩徳 (Hironori Harada):2、Jun Ho Jang:3、鈴木 憲史 (Kenshi Suzuki):4、通堂 満 (Mitsuru Tsudo):5、石川 隆之 (Takayuki Ishikawa):6、鵜池 直邦 (Naokuni Uike):7、日高 道弘 (Michihiro Hidaka):8、臼杵 憲祐 (Kensuke Usuki):9、清水 誠一 (Seiichi Shimizu):10、Yoo-Jin Kim:11、Hawk Kim:12、木崎 昌弘 (Masahiro Kizaki):13、千葉 滋 (Shigeru Chiba):14、南谷 泰仁 (Yasuhito Nannya):15、米村 雄士 (Yuji Yonemura):16、澤 正史 (Masashi Sawa):17、小倉 秀充 (Hidemi Ogura):18、仲里 朝周 (Tomonori Nakazato):19、熊谷 隆志 (Takashi Kumagai):20、木口 亨 (Toru Kiguchi):21、髙橋 健 (Takeshi Takahashi):22、入江 誠治 (Seiji Irie):23、Sung-Soo Yoon:24、Ho-Jin Shin:25、Young Don Joo:26、Yoo Hong Min:27、Sang Kyun Sohn:28、三谷 絹子 (Kinuko Mitani):29、澤田 賢一 (Kenichi Sawada):30、Je-Hwan Lee:31、Hyeoung-Joon Kim:32

1:Department of Hematology and Oncology, Osaka University, Osaka, Japan、2:Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan、3:Division of Hematology/Oncology, Sungkyunkwan University Samsung Medical Center, Seoul, Korea、4:Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan、5:Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan、6:Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan、7:Department of Hematology, Kyushu Cancer Center, Fukuoka, Japan、8:Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan、9:Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan、10:Department of Internal Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan、11:Department of Hematology, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea、12:Department of Hemato-Oncology, Ulsan University Hospital, Ulsan, Korea、13:Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan、14:Department of Hematology, University of Tsukuba, Tsukuba, Ibaraki, Japan、15:Department of Hematology & Oncology, The University of Tokyo Hospital, Tokyo, Japan、16:Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan、17:Department of Hematology and Oncology, Anjo Kosei Hospital, Aichi, Japan、18:Division of Hematology, Maebashi Red Cross Hospital, Gunma, Japan、19:Department of Hematology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan、20:Department of Hematology, Ohme Municipal General Hospital, Tokyo, Japan、21:Hematology, Japan Mutual Aid Association of Public School Teachers Chugoku Central Hospital, Hiroshima, Japan、22:Hematologic Disease Center, Gifu Municipal Hospital, Gifu, Japan、23:Department of Hematology, Japan Labour Health and Welfare Organization, Kanto Rosai Hospital, Kanagawa, Japan、24:Department of Internal Medicine, Hematology/Oncology, Seoul National University Hospital, Seoul, Korea、25:Department of Hematology / Oncology, Pusan National University Hospital, Busan, Korea、26:Department of Hemato-Oncology, InJe University Haeundae Paik Hospital, Busan, Korea、27:Department of Internal Medicine, Division of Hematology, Yonsei University Severance Hospital, Seoul, Korea、28:Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea、29:Department of Hematology and Oncology, Dokkyo Medical University Hospital, Tochigi, Japan、30:Department of Hematology, Nephrology, and Rheumatology, Akita University Hospital, Akita, Japan、31:Department of Hematology, Ulsan University Asan Medical Center, Seoul, Korea、32:Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea

Preliminary results of a randomized dose-finding study of darbepoetin alfa in MDS in Japan and Korea